Cargando…
Mechanisms underlying extensive Ser129-phosphorylation in α-synuclein aggregates
Parkinson’s disease (PD) is characterized neuropathologically by intracellular aggregates of fibrillar α-synuclein, termed Lewy bodies (LBs). Approximately 90% of α-synuclein deposited as LBs is phosphorylated at Ser129 in brains with PD. In contrast, only 4% of total α-synuclein is phosphorylated a...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472914/ https://www.ncbi.nlm.nih.gov/pubmed/28619113 http://dx.doi.org/10.1186/s40478-017-0452-6 |
_version_ | 1783244205385056256 |
---|---|
author | Arawaka, Shigeki Sato, Hiroyasu Sasaki, Asuka Koyama, Shingo Kato, Takeo |
author_facet | Arawaka, Shigeki Sato, Hiroyasu Sasaki, Asuka Koyama, Shingo Kato, Takeo |
author_sort | Arawaka, Shigeki |
collection | PubMed |
description | Parkinson’s disease (PD) is characterized neuropathologically by intracellular aggregates of fibrillar α-synuclein, termed Lewy bodies (LBs). Approximately 90% of α-synuclein deposited as LBs is phosphorylated at Ser129 in brains with PD. In contrast, only 4% of total α-synuclein is phosphorylated at Ser129 in brains with normal individuals. It is unclear why extensive phosphorylation occurs in the pathological process of PD. To address this issue, we investigated a mechanism and role of Ser129-phosphorylation in regulating accumulation of α-synuclein. In CHO cells, the levels of Ser129-phosphorylated soluble α-synuclein were maintained constantly to those of total α-synuclein in intracellular and extracellular spaces. In SH-SY5Y cells and rat primary cortical neurons, mitochondrial impairment by rotenone or MPP(+) enhanced Ser129-phosphorylation through increased influx of extracellular Ca(2+). This elevation was suppressively controlled by targeting Ser129-phosphorylated α-synuclein to the proteasome pathway. Rotenone-induced insoluble α-synuclein was also targeted by Ser129-phosphoryation to the proteasome pathway. Experiments with epoxomicin and chloroquine showed that proteasomal targeting of insoluble Ser129-phosphorylated α-synuclein was enhanced under lysosome inhibition and it reduced accumulation of insoluble total α-synuclein. However, in a rat AAV-mediated α-synuclein overexpression model, there was no difference in the number of total α-synuclein aggregates between A53T mutant and A53T plus S129A double mutant α-synuclein, although Ser129-phosphorylated α-synuclein-positive aggregates were increased in rats expressing A53T α-synuclein. These findings suggest that Ser129-phosphorylation occurs against stress conditions, which increases influx of extracellular Ca(2+), and it prevents accumulation of insoluble α-synuclein by evoking proteasomal clearance complementary to lysosomal one. However, Ser129-phosphorylation may provide an ineffective signal for degradation-resistant aggregates, causing extensive phosphorylation in aggregates. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40478-017-0452-6) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5472914 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-54729142017-06-21 Mechanisms underlying extensive Ser129-phosphorylation in α-synuclein aggregates Arawaka, Shigeki Sato, Hiroyasu Sasaki, Asuka Koyama, Shingo Kato, Takeo Acta Neuropathol Commun Research Parkinson’s disease (PD) is characterized neuropathologically by intracellular aggregates of fibrillar α-synuclein, termed Lewy bodies (LBs). Approximately 90% of α-synuclein deposited as LBs is phosphorylated at Ser129 in brains with PD. In contrast, only 4% of total α-synuclein is phosphorylated at Ser129 in brains with normal individuals. It is unclear why extensive phosphorylation occurs in the pathological process of PD. To address this issue, we investigated a mechanism and role of Ser129-phosphorylation in regulating accumulation of α-synuclein. In CHO cells, the levels of Ser129-phosphorylated soluble α-synuclein were maintained constantly to those of total α-synuclein in intracellular and extracellular spaces. In SH-SY5Y cells and rat primary cortical neurons, mitochondrial impairment by rotenone or MPP(+) enhanced Ser129-phosphorylation through increased influx of extracellular Ca(2+). This elevation was suppressively controlled by targeting Ser129-phosphorylated α-synuclein to the proteasome pathway. Rotenone-induced insoluble α-synuclein was also targeted by Ser129-phosphoryation to the proteasome pathway. Experiments with epoxomicin and chloroquine showed that proteasomal targeting of insoluble Ser129-phosphorylated α-synuclein was enhanced under lysosome inhibition and it reduced accumulation of insoluble total α-synuclein. However, in a rat AAV-mediated α-synuclein overexpression model, there was no difference in the number of total α-synuclein aggregates between A53T mutant and A53T plus S129A double mutant α-synuclein, although Ser129-phosphorylated α-synuclein-positive aggregates were increased in rats expressing A53T α-synuclein. These findings suggest that Ser129-phosphorylation occurs against stress conditions, which increases influx of extracellular Ca(2+), and it prevents accumulation of insoluble α-synuclein by evoking proteasomal clearance complementary to lysosomal one. However, Ser129-phosphorylation may provide an ineffective signal for degradation-resistant aggregates, causing extensive phosphorylation in aggregates. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40478-017-0452-6) contains supplementary material, which is available to authorized users. BioMed Central 2017-06-15 /pmc/articles/PMC5472914/ /pubmed/28619113 http://dx.doi.org/10.1186/s40478-017-0452-6 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Arawaka, Shigeki Sato, Hiroyasu Sasaki, Asuka Koyama, Shingo Kato, Takeo Mechanisms underlying extensive Ser129-phosphorylation in α-synuclein aggregates |
title | Mechanisms underlying extensive Ser129-phosphorylation in α-synuclein aggregates |
title_full | Mechanisms underlying extensive Ser129-phosphorylation in α-synuclein aggregates |
title_fullStr | Mechanisms underlying extensive Ser129-phosphorylation in α-synuclein aggregates |
title_full_unstemmed | Mechanisms underlying extensive Ser129-phosphorylation in α-synuclein aggregates |
title_short | Mechanisms underlying extensive Ser129-phosphorylation in α-synuclein aggregates |
title_sort | mechanisms underlying extensive ser129-phosphorylation in α-synuclein aggregates |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472914/ https://www.ncbi.nlm.nih.gov/pubmed/28619113 http://dx.doi.org/10.1186/s40478-017-0452-6 |
work_keys_str_mv | AT arawakashigeki mechanismsunderlyingextensiveser129phosphorylationinasynucleinaggregates AT satohiroyasu mechanismsunderlyingextensiveser129phosphorylationinasynucleinaggregates AT sasakiasuka mechanismsunderlyingextensiveser129phosphorylationinasynucleinaggregates AT koyamashingo mechanismsunderlyingextensiveser129phosphorylationinasynucleinaggregates AT katotakeo mechanismsunderlyingextensiveser129phosphorylationinasynucleinaggregates |